CYP2J2 and cardiac arrhythmia: Combined with the results of the present study, we can now conclude that the epoxy-metabolites produced by CYP2J2 or stabilized upon sEH inhibition exert a direct antiarrhythmic effect that protects the heart from arrhythmia even under conditions of severe hypertrophy and pump failure.